{
    "clinical_study": {
        "@rank": "134585", 
        "arm_group": [
            {
                "arm_group_label": "TAU + Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Treatment as Usual + Placebo"
            }, 
            {
                "arm_group_label": "TAU + Lithium", 
                "arm_group_type": "Active Comparator", 
                "description": "Treatment as Usual + Lithium"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary hypothesis of this confirmatory study is that lithium therapy will acutely\n      decrease suicidal ideation and/or suicidal behaviour in inpatients with a major depressive\n      episode (MDE, unipolar and bipolar disorder according to DSM IV criteria). The specific aim\n      is to test the hypothesis that lithium plus treatment as usual (TAU), compared to placebo\n      plus TAU, results in a significantly greater decrease in suicidal ideation and/or behaviour\n      over 5 weeks in inpatients with MDE."
        }, 
        "brief_title": "Randomized, Placebo-controlled Multicenter Trial of Lithium Plus Treatment as Usual (TAU) for Acute Suicidal Ideation and Behavior in Patients With Suicidal Major Depressive Episode", 
        "completion_date": {
            "#text": "September 2017", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Suicidal Ideation/Behavior", 
            "Depression"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder", 
                "Depressive Disorder, Major", 
                "Suicidal Ideation"
            ]
        }, 
        "detailed_description": {
            "textblock": "The study will consist of 254 adult patients, hospitalized for a major depressive episode\n      with suicidal ideation and/or behaviour who will be randomized to two groups of each 127\n      participants. All study participants will receive treatment as usual in the hospital,\n      including (psycho)pharmacological treatment and, if needed, psychotherapy plus a 5-week\n      course of lithium or placebo. Rating scales will be used daily resp. weekly to measure\n      suicidal ideation and/or behaviour, depression, anxiety, mixed/manic features and\n      impulsiveness. Experienced clinicians will rate suicidal ideation and/or behaviour as well\n      as depression twice a week and anxiety, mixed/manic features and impulsiveness once a week."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Major depressive episode; inpatient at screening visit; suicidal ideation/behaviour\n             present defined by a clinical rating of 8 on the Sheehan Suicidality Tracking Scale\n             (S-STS) and a rating of \u226520 on the Montgomery Asberg Depression Scale (MADRS) at both\n             screening and baseline visits; both gender, age 18 years.\n\n        Exclusion Criteria:\n\n          -  Contraindication for and history of lithium treatment within the past 6 months;\n             patient unable to tolerate lithium treatment in the past; comorbid\n             borderline/antisocial personality disorder, currently active substance dependency;\n             patients with acute or unstable severe medical conditions, patients unable to\n             understand the informed consent or involuntary inpatients, positive toxicology screen\n             (illegal drugs), pregnancy and lactation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "254", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 16, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02039479", 
            "org_study_id": "01KG1307"
        }, 
        "intervention": [
            {
                "arm_group_label": "TAU + Lithium", 
                "description": "Lithium as Add on to every necessary treatment as usual", 
                "intervention_name": "Lithium Carbonate", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "TAU + Placebo", 
                "description": "Placebo as ADD-on to every necessary treatment as usual", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Lithium", 
                "Lithium Carbonate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "anti-suicide", 
            "Lithium", 
            "Depression", 
            "suicidal Ideation/behavior"
        ], 
        "lastchanged_date": "January 16, 2014", 
        "location": [
            {
                "contact": {
                    "email": "burkhard.jabs@khdh.de", 
                    "last_name": "Burkhard Jabs, Prof", 
                    "phone": "+49 351 856 69", 
                    "phone_ext": "02"
                }, 
                "facility": {
                    "address": {
                        "city": "Dresden", 
                        "country": "Germany", 
                        "state": "Saxony", 
                        "zip": "01324"
                    }, 
                    "name": "Dept. of Psychiatry and Psychotherapy, Hospital of Dresden Neustadt"
                }, 
                "investigator": {
                    "last_name": "Burkhard Jabs, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "bschor@schlosspark-klinik.de", 
                    "last_name": "Tom Bschor, Prof.", 
                    "phone": "+49 30 3264 1352", 
                    "phone_ext": "3"
                }, 
                "facility": {
                    "address": {
                        "city": "Berlin", 
                        "country": "Germany", 
                        "zip": "14059"
                    }, 
                    "name": "Schlossparc-Clinic, Dept. of Psychiatry and Psychotherapy"
                }, 
                "investigator": {
                    "last_name": "Tom Bschor, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "georg.juckel@wkp.lwl.org", 
                    "last_name": "Georg Juckel, Prof.", 
                    "phone": "+49 234 5077", 
                    "phone_ext": "1100"
                }, 
                "facility": {
                    "address": {
                        "city": "Bochum", 
                        "country": "Germany", 
                        "zip": "44791"
                    }, 
                    "name": "Dept. of Psychiatry and Psychotherapy, Ruhr University Bochum"
                }, 
                "investigator": {
                    "last_name": "Georg Juckel, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "reif_a@klinik.uni-wuerzburg.de", 
                    "last_name": "Andreas Reif, Prof.", 
                    "phone": "+49 931 201", 
                    "phone_ext": "76403"
                }, 
                "facility": {
                    "address": {
                        "city": "Wuerzburg", 
                        "country": "Germany", 
                        "zip": "97080"
                    }, 
                    "name": "Dept. of Psychiatry and Psychotherapy"
                }, 
                "investigator": {
                    "last_name": "Andreas Reif, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized, Placebo-controlled Multicenter Trial of Lithium Plus Treatment as Usual (TAU) for Acute Suicidal Ideation and Behavior in Patients With Suicidal Major Depressive Episode", 
        "overall_contact": {
            "email": "michael.bauer@uniklinikum-dresden.de", 
            "last_name": "Michael Bauer, Prof.", 
            "phone": "+49 351 458", 
            "phone_ext": "2760"
        }, 
        "overall_contact_backup": {
            "email": "ute.lewitzka@uniklinikum-dresden.de", 
            "last_name": "Ute Lewitzka, MD", 
            "phone": "+49 351 458", 
            "phone_ext": "3671"
        }, 
        "overall_official": [
            {
                "affiliation": "Dept. of Psychiatry and Psychotherapy; TU Dresden", 
                "last_name": "Michael Bauer, Prof.", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Dept. of Psychiatry and Psychotherapy, TU Dresden", 
                "last_name": "Ute Lewitzka, MD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": [
                "Germany: Federal Institut for Drugs and Medical Devices", 
                "Germany: Federal Ministry of Education and Research"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change in the clinician administered (S-STS=Sheehan Suicidality Tracking Scale) total score between initial and final visit", 
            "measure": "S-STS", 
            "safety_issue": "No", 
            "time_frame": "5 Weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02039479"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Change of the total score of C-SSRS (Columbia-Suicide Severity Rating Scale) between start and final visit", 
            "measure": "C-SSRS", 
            "safety_issue": "No", 
            "time_frame": "5 weeks"
        }, 
        "source": "Technische Universit\u00e4t Dresden", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Technische Universit\u00e4t Dresden", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}